Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Field MSL Leadership Panel - MSL QA Session PART TWO with Vanessa Jacobsen, Amy Misnik, and Sue Watson
Summary
In this episode, Tom Caravela is joined by Amy Misnick, Vanessa Jacobson, and Sue Watson to explore a range of topics crucial for current and aspiring Medical Science Liaisons. The discussion covers the transition into the MSL role, including necessary certifications and experiences, and how to craft an effective resume using the right keywords. They also address the impact of the pandemic on MSL performance and the importance of virtual introductions to Key Opinion Leaders (KOLs). The speakers offer insights on demonstrating MSL value within organizations, overcoming experience barriers, and the criteria for ending KOL relationships. They conclude with advice for industry newcomers and a reminder to embrace growth opportunities.
We are part two of our Field MSL Leadership panel, MSL Q&A session with Vanessa Jacobsen, Amy Misnik, and Sue Watson.
In this episode we discuss:
- What experience or certification can help someone transition into the MSL position
- How is MSL performance assessed during COVID and the best advice to achieve success
- What keywords are important to include in the resume
- Advice for a newly hired MSL during COVID on how to make a lasting impact when introducing themselves to KOLs for the first time virtually
- How to overcome the job listed requirement of must have prior MSL experience (as an aspiring MSL)
- How’s training evolving to keep up with the pace of healthcare innovation
- Showing one’s value internally as an MSL
- Under what conditions should MSLs discontinue KOL relationship or at what point should an MSL stop trying to connect
- Advice moving into the rest of COVID and into 2021
- Advice to younger self
Medical Science Liaison, MSL transition, Key Opinion Leaders, MSL resume keywords, MSL virtual introductions
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Article
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
Article
Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
Article
iNIZIO